A less-than-encouraging clinical trial for an investigative medicine was the news driving down Incyte (NASDAQ: INCY) stock ...
Medical Device Network on MSN3d
Leadoptik and Stanford Medicine to explore imaging in lung biopsy proceduresLeadoptik has entered a research partnership with Stanford Medicine, focusing on real-time optical imaging usage in lung ...
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
Twice-daily application of ruxolitinib cream demonstrated an ability to reduce itching and blistering in prurigo nodularis, a ...
LEADOPTIK Inc., a Silicon Valley-based medical imaging company today announced that it has entered into a research ...
allAfrica.com on MSN2d
Africa: A Jab That Could Protect Against HIV for a Year At a Time, and Other Highlights From Major ConferenceA single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
Critics say a new, broader definition of high-risk plaque opens the door to more tests, diagnoses, and invasive procedures, steering us down a potentially harmful path.
Dr. Yang Jian, leader of the team that published the Nature article unveiling a new method known simply as "gsMap" Photo: ...
DO you snore? Between 25 to 50 percent of adults snore regularly, and occasional snoring is almost universal. If one snores and wakes up tired and feeling sleep-deprived most ...
Incyte's experimental skin disease drug met the main goal of two separate late-stage trials, but data showed that it was not as effective as in its prior studies, sending the drugmaker's shares down ...
A scientific debate has emerged regarding the possibility of producing 'dark oxygen' without sunlight, through metallic nodules found deep in the ocean. The discovery challenges long-held beliefs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback